Agios Pharmaceuticals (AGIO) Other Non Operating Income (2021 - 2025)
Historic Other Non Operating Income for Agios Pharmaceuticals (AGIO) over the last 5 years, with Q4 2025 value amounting to $113000.0.
- Agios Pharmaceuticals' Other Non Operating Income fell 9303.76% to $113000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 million, marking a year-over-year decrease of 6984.74%. This contributed to the annual value of $2.0 million for FY2025, which is 6984.74% down from last year.
- According to the latest figures from Q4 2025, Agios Pharmaceuticals' Other Non Operating Income is $113000.0, which was down 9303.76% from $67000.0 recorded in Q3 2025.
- In the past 5 years, Agios Pharmaceuticals' Other Non Operating Income registered a high of $6.5 million during Q2 2021, and its lowest value of $67000.0 during Q3 2025.
- Its 5-year average for Other Non Operating Income is $1.9 million, with a median of $1.6 million in 2024.
- In the last 5 years, Agios Pharmaceuticals' Other Non Operating Income soared by 3781.3% in 2024 and then tumbled by 9594.19% in 2025.
- Quarter analysis of 5 years shows Agios Pharmaceuticals' Other Non Operating Income stood at $3.3 million in 2021, then crashed by 58.48% to $1.4 million in 2022, then rose by 26.23% to $1.7 million in 2023, then decreased by 5.25% to $1.6 million in 2024, then tumbled by 93.04% to $113000.0 in 2025.
- Its Other Non Operating Income was $113000.0 in Q4 2025, compared to $67000.0 in Q3 2025 and $523000.0 in Q2 2025.